Yen-Ming Hsu
Inventor
Stats
- 23 US patents issued
- 46 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 23 US Patents Issued
- 46 US Applications Filed
- 230 Total Citation Count
- Sep 7, 2022 Most Recent Filing
- Jun 7, 1995 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
AB BIOSCIENCES, INC. | 2
1 | 2013
2016 |
UCB Parma S.A. | 1
| 2008
|
BIOGEN IDEC MA INC. | 1
1 | 2005
2009 |
BIOGEN, INC. | 1
3 1 | 2002
2003 2005 |
Genentech, Inc. | 1
1 | 2006
2013 |
BIOGEN MA INC. | 4
1 1 2 5 2 4 2 6 5 5 1 2 | 1995
1996 2002 2004 2006 2008 2010 2011 2012 2013 2014 2015 2016 |
UCB BIOPHARMA SPRL | 2
2 2 1 | 2008
2012 2014 2016 |
Inventor Addresses
Address | Duration |
---|---|
Concord, MA, US | Apr 18, 19 - Oct 31, 23 |
Hsinchu, TW | Mar 26, 15 - Mar 26, 15 |
LEXINGTON, MA, US | Feb 21, 13 - May 04, 23 |
Lexington, MA | Jun 24, 97 - Oct 25, 07 |
Lexington, MA, US | Sep 03, 09 - Jul 07, 22 |
New Taipei City, TW | Mar 05, 20 - Apr 22, 21 |
New Taipei, TW | Feb 09, 21 - Sep 26, 23 |
TAIPEI CITY, TW | Jan 28, 21 - Jan 28, 21 |
Technology Profile
Technology | Matters | |
---|---|---|
A44C: | JEWELLERY; BRACELETS; OTHER PERSONAL ADORNMENTS; COINS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 23 |
A61M: | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11801286 | 2023 | Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use | 0 |
11769032 | 2023 | Electronic system, portable electronic device and counting information updating method | 0 |
2023/0135,399 | 2023 | BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF | 0 |
2022/0233,658 | 2022 | RECOMBINANT INTRAVENOUS IMMUNOGLOBULIN (RIVIG) COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND USE | 0 |
2022/0213,208 | 2022 | ANTI-BCMA ANTIBODIES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.